Skip to content
Investing Insights Report

Investing Insights Report

  • Home
  • Business
  • Domestic
  • Economy
  • Money
  • Top News
  • Newsletters

Obesity stocks slump on Novo’s underwhelming 2026 sales forecast

February 4, 2026

Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss market.


Read Full Article →

Source: https://www.reuters.com/business/healthcare-pharmaceuticals/…

Latest News

Post navigation

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Broadcom and Nvidia Stocks Rise. How Google’s AI Spending Will Boost the Chip Makers.

Related Posts

Are Computer and Technology Stocks Lagging Corning (GLW) This Year?

Here is how Corning (GLW) and Electrovaya Inc. (ELVA) have performed compared to their sector so far this year.

Top 3 Real Estate Stocks That Are Set To Fly In Q1

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.

Are Business Services Stocks Lagging ENPRO INC (NPO) This Year?

Here is how Enpro (NPO) and Quad/Graphics (QUAD) have performed compared to their sector so far this year.

Search

Recent Posts

  • Best Value Stocks to Buy for May 29th
  • Should iShares Top 20 U.S. Stocks ETF (TOPT) Be on Your Investing Radar?
  • Blue Origin rocket explosion: How space stocks are reacting just weeks before highly anticipated SpaceX IPO
  • Overhyped AI Stocks: 1 Pure-Play Infrastructure Stock Under $30 to Buy Right Now
  • Dollar Tree Soars 17%, Dollar General Jumps 5%: Here’s Why Discount Store Stocks Are Catching a Bid

Categories

  • Business
  • Domestic
  • Economy
  • Latest News
  • Money
  • Newsletters
  • Politics
  • Top News
  • Uncategorized
  • Home
  • Disclaimer
  • Privacy Policy of GBM Media Group, LLC
  • Terms of Service/Use Agreement
  • Contact Us

Copyright © 2026 Investing Insights Report | Visionary News by Ascendoor | Powered by WordPress.